These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1905009)

  • 1. Quantitative analysis of the active tablet ingredient by powder X-ray diffractometry.
    Suryanarayanan R; Herman CS
    Pharm Res; 1991 Mar; 8(3):393-9. PubMed ID: 1905009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the relative amounts of anhydrous carbamazepine (C15H12N2O) and carbamazepine dihydrate (C15H12N2O.2H2O) in a mixture by powder x-ray diffractometry.
    Suryanarayanan R
    Pharm Res; 1989 Dec; 6(12):1017-24. PubMed ID: 2622857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of Drug Particle Size in Intact Tablets by 2-Dimensional X-Ray Diffractometry.
    Thakral S; Thakral NK; Suryanarayanan R
    J Pharm Sci; 2018 Jan; 107(1):231-238. PubMed ID: 28899809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivariate calibration of energy-dispersive X-ray diffraction data for predicting the composition of pharmaceutical tablets in packaging.
    Crews C; Kenny PS; O'Flynn D; Speller RD
    J Pharm Biomed Anal; 2018 Mar; 151():186-193. PubMed ID: 29353807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability in commercial carbamazepine samples--impact on drug release.
    Flicker F; Eberle VA; Betz G
    Int J Pharm; 2011 May; 410(1-2):99-106. PubMed ID: 21435386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the Sensitivity of Transmission Raman Spectroscopy for Polymorph Detection in Pharmaceutical Tablets.
    Feng H; Bondi RW; Anderson CA; Drennen JK; Igne B
    Appl Spectrosc; 2017 Aug; 71(8):1856-1867. PubMed ID: 28357920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of Fillers and Binders on the Accuracy of Tablet Subdivision.
    Pereira GRS; Taveira SF; Cunha-Filho M; Marreto RN
    AAPS PharmSciTech; 2018 Oct; 19(7):2929-2933. PubMed ID: 30120694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compatibility studies between carbamazepine and tablet excipients using thermal and non-thermal methods.
    Joshi BV; Patil VB; Pokharkar VB
    Drug Dev Ind Pharm; 2002 Jul; 28(6):687-94. PubMed ID: 12149961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving Dissolution Rate of Carbamazepine-Glutaric Acid Cocrystal Through Solubilization by Excess Coformer.
    Yamashita H; Sun CC
    Pharm Res; 2017 Dec; 35(1):4. PubMed ID: 29288433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes.
    Kushner J; Langdon BA; Hicks I; Song D; Li F; Kathiria L; Kane A; Ranade G; Agarwal K
    J Pharm Sci; 2014 Feb; 103(2):527-38. PubMed ID: 24375069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Simultaneous quantitative determination of multicomponents in tablets based on terahertz time-domain spectroscopy].
    Chen T; Li Z; Mo W; Hu FR
    Guang Pu Xue Yu Guang Pu Fen Xi; 2013 May; 33(5):1220-5. PubMed ID: 23905323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-destructive determination of the coating film thickness by X-ray powder diffractometry and correlation with the dissolution behavior of film-coated tablets.
    Yamada H; Terada K; Suryanarayanan R
    J Pharm Biomed Anal; 2010 Mar; 51(4):952-7. PubMed ID: 19945243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the analytical methods (solid state NMR, FT-IR, PXRD) in the analysis of the solid drug forms with low concentration of an active ingredient - 17-β-estradiol case.
    Szeleszczuk Ł; Jurczak E; Zielińska-Pisklak M; Harwacki J; Pisklak DM
    J Pharm Biomed Anal; 2018 Feb; 149():160-165. PubMed ID: 29121569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-ray powder diffractometry of intact film coated tablets--an approach to monitor the physical form of the active pharmaceutical ingredient during processing and storage.
    Yamada H; Suryanarayanan R
    J Pharm Sci; 2007 Aug; 96(8):2029-36. PubMed ID: 17541977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study of the properties of tablets from mixtures of two size degrees of alpha-lactose monohydrate and microcrystalline cellulose].
    Muzíková J
    Ceska Slov Farm; 2006 Mar; 55(2):72-7. PubMed ID: 16570584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of active ingredients in tablets by chemometric processing of X-ray diffractometric data.
    Komsta Ł; Maurin JK
    Talanta; 2010 Jul; 82(2):850-3. PubMed ID: 20602980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of dissolution properties of Carbamazepine through application of the liquisolid tablet technique.
    Tayel SA; Soliman II; Louis D
    Eur J Pharm Biopharm; 2008 May; 69(1):342-7. PubMed ID: 17949959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.
    Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS
    Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enabling the Tablet Product Development of 5-Fluorocytosine by Conjugate Acid Base Cocrystals.
    Perumalla SR; Paul S; Sun CC
    J Pharm Sci; 2016 Jun; 105(6):1960-1966. PubMed ID: 27238493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.